1. In BE's history of present illness, which of the following clinical signs/symptoms are consistent with a diagnosis of binge-eating disorder?
A. A sense of lack of control over eating during the episode
B. Eating until uncomfortably full
C. Eating alone out of embarrassment
D. All of the above
2. If you were to review the clinical history of BE, which of the following would most accurately describe her as a result of her binge-eating disorder?
A. Repeated history of weight loss followed by weight gain
B. Low weight at the time of clinical presentation
C. Normal weight with an increased focus on exercise
D. Preoccupation with being thin
3. Part of the diagnostic assessment for binge-eating disorder should include an evaluation for which common co-occurring disorder?
A. Attention deficit hyperactivity disorder
B. Schizoaffective disorder
C. Major depression
D. Delusional disorder
4. Eating disorders including anorexia nervosa, bulimia nervosa, and binge-eating disorder have been associated with dysfunction of which of the following neurotransmitters?
A. Serotonin
B. Dopamine
C. Norepinephrine
D. All the above
5. Which medical complication of binge-eating disorder is BE at highest risk for developing?
A. Gastroesophageal reflux disease
B. Hypothyroidism
C. Osteoporosis
D. Dental caries
6. BE asks the following question, “What non-medication treatment works the best for binge-eating disorder?” Which of the following answers is the correct response?
A. Cognitive Behavioral Therapy (CBT)
B. Interpersonal Therapy (IPT)
C. Dialectical Behavior Therapy (DBT)
D. Bright Light Therapy (BLT)
7. If BE were to insist upon using a medication treatment that is specifically FDA approved for binge-eating disorder, which one of the medications below would meet that criteria?
A. Sertraline
B. Topiramate
C. Lisdexamfetamine
D. Imipramine
8. If BE is prescribed sertraline as indicated in the plan of therapy, which side effects is she most likely to experience?
A. Headache, insomnia, anxiety, sexual dysfunction
B. Sedation, cognitive impairment, dizziness, nephrolithiasis
C. Dry mouth, insomnia, increased heart rate, anxiety
D. Sedation, constipation, dizziness, blurred vision
9. If BE were instead prescribed lisdexamfetamine, counseling should include which of the following points?
A. Lisdexamfetamine is a controlled substance and does not allow for refills.
B. Lisdexamfetamine may cause an increase in blood pressure and heart rate.
C. Lisdexamfetamine may cause anxiety and a sense of feeling jittery.
D. All the above
10. BE is willing to try a pharmacologic treatment approach for her moderate binge-eating disorder however, she is not willing to accept the use of a controlled substance due to the risk of dependence, she doesn't want to feel “slowed down”, and she is fearful of using sertraline because she has heard it causes tremors and more diarrhea and stomach upset. Which medication would be the best treatment option for her?
A. Divalproex sodium
B. Fluoxetine
C. Topiramate
D. Orlistat
11. If BE were to be placed on one of the following medications for binge-eating disorder, which one would require you to provide education related to the risk of developing nephrolithiasis?
A. Lisdexamfetamine
B. Sertraline
C. Topiramate
D. Venlafaxine
12. Which statement is TRUE regarding the use of antidepressant medication in the treatment of binge-eating disorder?
A. Antidepressants have been associated with reducing binge-eating frequency and improving depression symptoms.
B. Antidepressants have been associated with reducing binge-eating frequency but their use is limited because of increased intolerability.
C. Antidepressants have been associated with reducing binge-eating frequency and doses are often titrated higher than doses usually used for depression.
D. A and C only
E. All of the above
13. In a patient who presents with binge-eating disorder and is treated with fluoxetine, most clinical trials examining the acute effects of medication are how long in duration?
A. 4 to 8 weeks
B. 6 to 24 weeks
C. 12 to 36 weeks
D. 52 weeks
14. Orlistat in combination with a calorie-restricted diet has demonstrated benefit in treating binge-eating disorder, however its use is most likely to be limited by which of the following?
A. Drug interactions
B. Gastrointestinal intolerability
C. Dosing limitations
D. Electrolyte disturbances
15. Which medication in limited studies has been associated with reducing binge-eating and weight loss in treating binge-eating disorder, but its use has been limited primarily because of intolerability, notably psychological effects and cognitive impairment?
A. Lisdexamfetamine
B. Venlafaxine
C. Fluoxetine
D. Zonisamide
